SPY330.44-4.06 -1.21%
DIA276.82-2.08 -0.75%
IXIC10,715.00-195.28 -1.79%

LogicBio Therapeutics Q1 EPS $(0.410) Down From $(0.340) YoY

LogicBio Therapeutics (NASDAQ:LOGC) reported quarterly losses of $(0.410) per share. This is a 20.59 percent decrease over losses of $(0.340) per share from the same period last year.

Benzinga · 05/11/2020 20:26

LogicBio Therapeutics (NASDAQ:LOGC) reported quarterly losses of $(0.410) per share. This is a 20.59 percent decrease over losses of $(0.340) per share from the same period last year.